Neuroscience at the heart of European research

This week, under the sunny skies of Nice, I had the pleasure of attending the General Assembly of the European research consortium AIMS-2-TRIALS.

Human Neurodiversity: An Asset for Teams

We exchanged ideas on how scientific research can improve the quality of life for neurodivergent individuals, including autistic people, those with ADHD, or dyslexia, who collectively represent over 15% of the population.

The entrenched misconception that these are illnesses persists. Yet, these conditions are part of natural human variation, fully contributing to our neurodiversity.

Our discussions included genetic markers and gut microbiota, as well as topics related to wellbeing and stigma.

Cognitive Biases Affect Our Social Representations

Negative social perceptions, unconscious cognitive biases, and persistent prejudices continue to hinder the inclusive "living together" that allows humanity to achieve great things, like building cathedrals. Thus, research has a critical role, not only in advancing scientific understanding but also in reshaping societal perceptions and practices.

Participatory Basic Research Impacts Daily Life

AIMS-2-TRIALS, coordinated by Dr. Declan Murphy (King’s College London), aims to bridge the gap between fundamental research and daily life by developing personalized approaches that tangibly impact the lives of individuals identified as neurodivergent or atypical.

These enriching European exchanges during the AIMS-2-TRIALS General Assembly highlight how participatory research contributes to science that is actively responsive to societal needs.

— Vincent Grimaldi de Puget